Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (1-10 of 785) with videos related to

Pageof 79
Sort By:
Blood|July 28, 2017
How I treat myeloma with new agentsPhilippe Moreau
Blood|September 3, 2011
RIC alloSCT in MM: a long way to goPhilippe Moreau
Blood|December 3, 2011
PET-CT in MM: a new definition of CRPhilippe Moreau
Seminars in Hematology|June 26, 2012
The future of therapy for relapsed/refractory multiple myeloma: emerging agents and novel treatment strategiesPhilippe Moreau
Blood|June 30, 2012
Death of frontline allo-SCT in myelomaPhilippe Moreau
Expert Review of Anticancer Therapy|July 11, 2009
Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myelomaPhilippe Moreau
Expert Review of Hematology|February 14, 2014
The emerging role of carfilzomib combination therapy in the management of multiple myelomaPhilippe Moreau
Presse Medicale (Paris, France : 1983)|September 14, 2006
[New drugs for myeloma]Philippe Moreau
Blood|October 5, 2013
Panobinostat to revert bortezomib resistancePhilippe Moreau
Blood|August 16, 2014
Oral therapy for multiple myeloma: ixazomib arriving soonPhilippe Moreau
Pageof 79

Showing results (1-10 of 785) with videos related to

Sort By:
Pageof 79
Blood|July 28, 2017
How I treat myeloma with new agentsPhilippe Moreau
Blood|September 3, 2011
RIC alloSCT in MM: a long way to goPhilippe Moreau
Blood|December 3, 2011
PET-CT in MM: a new definition of CRPhilippe Moreau
Seminars in Hematology|June 26, 2012
The future of therapy for relapsed/refractory multiple myeloma: emerging agents and novel treatment strategiesPhilippe Moreau
Blood|June 30, 2012
Death of frontline allo-SCT in myelomaPhilippe Moreau
Expert Review of Anticancer Therapy|July 11, 2009
Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myelomaPhilippe Moreau
Expert Review of Hematology|February 14, 2014
The emerging role of carfilzomib combination therapy in the management of multiple myelomaPhilippe Moreau
Presse Medicale (Paris, France : 1983)|September 14, 2006
[New drugs for myeloma]Philippe Moreau
Blood|October 5, 2013
Panobinostat to revert bortezomib resistancePhilippe Moreau
Blood|August 16, 2014
Oral therapy for multiple myeloma: ixazomib arriving soonPhilippe Moreau
Pageof 79